Skip to content

InQu Paste Mix Plus 1.25cc IQSP-PP-101

by Arteriocyte Medical Systems, Inc

InQu Paste Mix Plus 1.25cc IQSP-PP-101 is a Class II device made by Arteriocyte Medical Systems, Inc, cleared under FDA 510(k) K103799 on 29 Aug 2011 and listed in FDA GUDID since 1 Aug 2018 (UDI-DI M896IQSPPP1010), active as of 8 Nov 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 8 Nov 2026

Documents

510(k) K103799

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberM896IQSPPP1010 UDI-DI Date1 Aug 2018ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK103799 Date29 Aug 2011DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K103799 decided 29 Aug 2011 Active
  • FDA GUDID UDI-DI M896IQSPPP1010 listed 1 Aug 2018 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K103799
  2. Listed FDA GUDID M896IQSPPP1010

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
InQu Paste Mix Plus 1.25cc
Generic name
Synthetic bone graft
Model / Ref / Catalog
IQSP-PP-101
Primary DI / UDI-DI
M896IQSPPP1010
510(k) Number
FDA product code
MQV
GMDN term
Synthetic bone graft
Device class
Class II
Regulation number
888.3045
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Synthetic bone graft.

Other devices from Arteriocyte Medical Systems, Inc

See all devices from Arteriocyte Medical Systems, Inc →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)